p777 online casino
Man City stumble again while Arsenal and Bayern Munich earn dominant wins
NEW YORK and SAN FRANCISCO, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Nasdaq Private Market (NPM) , a leading provider of secondary liquidity solutions to private companies, employees, and investors, announced today that it has promoted Rotem David , Parul Dubey, Sharif Khaleel , and Chris Setaro to new roles on its Executive Leadership Team. Rotem David has been promoted to Chief Product and Technology Officer (CPTO) . At NPM, he is an active member of the company’s Executive Leadership Team. In Mr. David’s new role, he will lead NPM’s product and technology divisions worldwide, responsible for setting and executing the product roadmap as well as effectively bridging the gap between product vision and technical feasibility. He will oversee tech infrastructure, engineering, QA, and product. Mr. David has spent more than 10 years building out NPM’s portfolio of products which offers liquidity and data across various transaction and client types. Prior to NPM, he held lead engineering roles at SecondMarket and Nasdaq, Inc and is credited with helping to pioneer the first tender offer solution revolutionizing the way private companies provide secondary liquidity to their shareholders. Parul Dubey has been promoted to Managing Director and Head of the Private Client Group . In her new role, she now joins the Executive Leadership Team. Ms. Dubey will lead the development of NPM’s retail business to service individuals, family offices, and mid-sized entities. Previously, she was General Manager of the Capital Markets division, where she helped build the business from inception. Ms. Dubey was instrumental in launching several capstone products, including buy-side auctions and SecondMarketTM. Prior to NPM, she worked at Wellington Management as an Investment Specialist responsible for global fund launches and distribution for private equity and healthcare hedge funds. Ms. Dubey also held investment roles at a buyout firm and served on the Board of Steven Feller P.E. (a portfolio company). She started her career at PIMCO, servicing managed separate accounts for sovereign wealth funds, central banks, and family offices in the Middle East and Africa. Sharif Khaleel has been promoted to Managing Director and Head of Institutional Trading . At NPM, he is an active member of the company’s Executive Leadership Team. In his new role, Mr. Khaleel will lead the trading desk, overseeing relationships with institutional clients and broker-dealers. He has nearly 25 years of financial services experience. Prior to NPM, Mr. Khaleel was a Managing Director at Zanbato, where he specialized in executing institutionally sized blocks of private securities. Earlier in his career, he served as a Senior Portfolio Trader at BNY Mellon. Mr. Khaleel has also held various roles on the buy side, including Derivatives and Risk Analyst at Stillwater Investment Management, Senior Trader at Farallon Capital Management, and International Portfolio and Macro Trader at BlackRock, where he spent over four years. Chris Setaro has been promoted to Chief Compliance, Regulatory, and Risk Officer . At NPM, he is an active member of the company’s Executive Leadership Team. Mr. Setaro will now oversee all compliance, regulatory affairs, and risk management functions for the company worldwide. Prior to NPM, he was a Senior Vice President and the Head of Global Risk at Forge Global Inc. Previously, Mr. Setaro was the Global Chief Compliance Officer of SharesPost, Inc. and Chief Compliance Officer for its broker-dealer subsidiary SharesPost Financial Corporation. Earlier in his career, he was a Vice President at Nasdaq, Inc. serving as the Chief Compliance Officer for several of its broker-dealers. “As our business continues to evolve, we are focused on adding talented people and valuable resources to strengthen our company and core products. I am confident that Rotem, Parul, Sharif, and Chris will each position us for continued success and accelerate our ambitions to be a key partner to participants across the private market ecosystem,” said Tom Callahan, Chief Executive Officer, Nasdaq Private Market . “I am proud of their commitment to NPM thus far and look forward to their future contributions.” NPM partners with some of the world’s fastest-growing, venture-backed private companies to facilitate company-sponsored liquidity programs. Its electronic SecondMarket TM trading marketplace is gaining adoption by sellers and buyers who trade private company shares. The company’s Transfer and Settlement product efficiently manages share transfer activity from match through settlement for some of the most sophisticated private companies and investors. Its private market premium data product Tape DTM helps investors and entities better evaluate global investment opportunities. As an industry-leading provider in the secondary market, NPM has executed $55+ billion in transactional value across 760+ company-sponsored liquidity programs for venture-backed private companies as well as 200,000+ individual eligible shareholders and investors. About Nasdaq Private Market Nasdaq Private Market provides liquidity solutions for private companies, employees, and investors throughout each stage of the pre-IPO lifecycle. In 2013, the company was founded within Nasdaq, Inc. Today it is an independent company with strategic investments from Nasdaq, Allen & Company, Bank of America, BNP Paribas, Citi, DRW Venture Capital, Goldman Sachs, HiJoJo Partners, Morgan Stanley, UBS, and Wells Fargo. Learn more at www.nasdaqprivatemarket.com . Visit LinkedIn and X for the latest company news. Media Contacts Nasdaq Private Market Amanda Gold Chief Marketing Officer Amanda.Gold@npm.com Disclosures and Disclaimers NPM is not: (a) a registered exchange under the Securities Exchange Act of 1934; (b) a registered investment adviser under the Investment Advisers Act of 1940; or (c) a financial or tax planner and does not offer legal or financial advice to any user of the NPM website or its services. Securities-related services are offered through NPM Securities, LLC, a registered broker-dealer and alternative trading system, and member FINRA/SIPC. Transactions in securities conducted through NPM Securities, LLC are not listed or traded on The Nasdaq Stock Market LLC, nor are the securities subject to the same listing or qualification standards applicable to securities listed or traded on The Nasdaq Stock Market LLC. Please read these other important disclosures and disclaimers about NPM found here: https://www.nasdaqprivatemarket.com/disclosures-disclaimer/
Vaccine expert Paul Offit is ‘shocked’ by RFK Jr.’s nomination to oversee US healthAir Canada to bar carry-on bags for lowest-fare customers
EAST RUTHERFORD, N.J. (AP) — New York Giants quarterback Tommy DeVito came out of his first start of the season with a sore throwing arm and his status for Thursday's game against the Cowboys in Dallas is uncertain. DeVito was not listed on Monday's injury report and coach Brian Daboll said he did not know about the injury to the quarterback's right arm until just before the team had a walkthrough practice on Tuesday. Daboll said he was hopeful DeVito would play, but he added that backup Drew Lock will get a couple of extra snaps in the short workout. “If Tommy is good, then Tommy will be the guy,” Daboll said. Having played on Sunday, the Giants (2-9) are prepping for the Cowboys (4-7) with walkthroughs. After the workout on Tuesday, DeVito said his whole body was still sore, even his neck. He planned to test his arm on Wednesday before the team headed to Dallas. “The plan is to play," DeVito said. “We’ll see how I feel tomorrow. Hopefully wake up feeling a little bit better after I get some more treatment today. Looking forward to tomorrow.” DeVito was given the starting job last week when Daboll benched Daniel Jones after five straight losses. Jones asked co-owner John Mara to cut him on Friday and the team released him so he could pursue other opportunities after he cleared waivers on Monday, which he did. DeVito was 21 of 31 for 189 yards in a 30-7 loss to the Tampa Bay Buccaneers. He was sacked four times and missed one play in the fourth quarter after being hit hard after making a throw. Lock said the uncertainty about playing is the life of a backup. He noted playing one play after DeVito was hurt in the fourth quarter was a first for him. “Always got to be ready,” he said. “No matter what the week, no matter what the situation is, just playing like you’re going to go in there and play. My mindset didn’t change this week, and we’ll see how the rest of the week shakes out.” AP NFL: https://apnews.com/hub/nflTEL AVIV, Israel (AP) — Israeli Prime Minister Benjamin Netanyahu underwent successful surgery Sunday to have his prostate removed, hospital officials said, a procedure that came as he manages multiple crises including the war in Gaza and his trial for alleged corruption . Netanyahu, who has had a series of health issues in recent years, has gone to great lengths to bolster a public image of himself as a healthy, energetic leader. During his trial this month, he boasted about working 18-hour days, accompanied by a cigar. But as Israel's longest-serving leader, such a grueling workload over a total of 17 years in power could take a toll on his well-being. Netanyahu, 75, is among older world leaders including U.S. President Joe Biden, 82 , President-elect Donald Trump, 78 , Brazil's President Luiz Inácio Lula da Silva , 79, and Pope Francis , 88, who have come under scrutiny for their age and health issues. Netanyahu's latest condition is common in older men, but the procedure has had some fallout. The judges overseeing his trial accepted a request from his lawyer on Sunday to call off three days of testimony scheduled this week. The lawyer, Amit Hadad, had argued that Netanyahu would be fully sedated for the procedure and hospitalized for “a number of days.” Jerusalem's Hadassah Medical Center announced late Sunday that the procedure had been “completed successfully.” Justice Minister Yariv Levin, a close ally, served as acting prime minister during the operation. Netanyahu is expected to remain hospitalized for several days. With so much at stake, Netanyahu’s health in wartime is a concern for both Israelis and the wider world. As Israel’s leader, Netanyahu is at the center of major global events that are shifting the Middle East . With the dizzying pace of the past 14 months, being incapacitated for even a few hours can be risky. Netanyahu will be in the hospital at a time when international mediators are pushing Israel and Hamas to reach a ceasefire in Gaza and as fighting between Israel and Yemen’s Iran-backed Houthi rebels intensifies . Prostate issues are common and in many cases easily treatable. Still, the procedure puts a dent in Netanyahu’s image of vigor at a time when he would want to project strength more than ever, both to an Israeli audience navigating constant threats as well as to Israel’s enemies looking to expose its weaknesses. Netanyahu insists he is in excellent health. His office releases footage of him touring war zones in full protective gear flanked by military officers, or meeting with defense officials on windswept hilltops in youthful dark shades and puffer jackets. But that image was shattered last year when Netanyahu’s doctors revealed that he had a heart condition , a problem that he had apparently long known about but concealed from the public. A week after a fainting spell, Netanyahu was fitted with a pacemaker to control his heartbeat. Only then did staff at the Sheba Medical Center reveal that Netanyahu has for years experienced a condition that can cause irregular heartbeats. The revelation came as Netanyahu was dealing with massive anti-government protests. The news about a chronic heart problem stoked further anger and distrust during extreme political polarization in Israel. Last year, Netanyahu was rushed to the hospital for what doctors said likely was dehydration . He stayed overnight, prompting his weekly Cabinet meeting to be delayed. Earlier this year, Netanyahu underwent hernia surgery , during which he was under full anesthesia and unconscious. Levin served as acting prime minister during the operation. According to Netanyahu’s office, the Israeli leader was diagnosed with a urinary tract infection on Wednesday stemming from a benign enlargement of his prostate. The infection was treated successfully with antibiotics, but doctors said the surgery was needed in any case. Complications from prostate enlargement are common in men in their 70s and 80s, Dr. Shay Golan, head of the oncology urology service at Israel’s Rabin Medical Center, told Israeli Army Radio. Golan spoke in general terms and was not involved in Netanyahu’s care or treatment. He said an enlarged prostate can block proper emptying of the bladder, leading to a build-up of urine that can lead to an infection or other complications. After medicinal treatment, doctors can recommend a procedure to remove the prostate to prevent future blockages, Golan said. In Netanyahu’s case, because the prostate is not cancerous, Golan said doctors were likely performing an endoscopic surgery, carried out by inserting small instruments into a body cavity, rather than making surgical cuts in the abdomen to reach the prostate. The procedure lasts about an hour, Golan said, and recovery is quick. He said that aside from catheter use for one to three days after the procedure, patients can return to normal activity without significant limitations. AP correspondent Isaac Scharf contributed reporting.
Both Oklahoma and Providence are hoping they'll have key pieces back in place when the two undefeated teams square off in the first round of the Battle 4 Atlantis on Wednesday in Paradise Island, Bahamas. The Friars (5-0) are expected to have Bryce Hopkins available, according to a report from Field of 68. Hopkins was averaging 15.5 points and 8.6 rebounds last season before suffering a torn anterior cruciate ligament Jan. 3. He returned to full-go practices last week, and Tuesday, Providence coach Kim English said Hopkins would be a "game-time decision" against the Sooners. "It's been a process," English said. "We're not rushing it." But English praised Hopkins' progress since the Friars' last game, Nov. 19, when Hopkins went through pregame warmups. "I thought he looked better than I remembered," English said. "He's been in our system for the past year. His patience, his understanding, his versatility on offense and defense ... it's been great to see him in practice." The Sooners (4-0) are hopeful that they'll get Brycen Goodine back. Goodine played for the Friars for two seasons from 2020-22 before transferring to Fairfield for two seasons and then to Oklahoma this offseason. Goodine suffered an ankle injury in the Sooners' opener Nov. 4 and has not played since. "He's a really tough kid and trying to push through it," Oklahoma coach Porter Moser said. "It will truly be one of those game-time decisions. He hasn't gone a full practice yet, just been pieces of practices." Playing with Goodine and Jadon Jones, expected to be two of the Sooners' top outside shooters, Moser said he's learned plenty about his team's offense. "When you're down those shooters, it's really a great weapon to know that a lot of other guys can knock down the open shot," Moser said. "It's been a huge takeaway." The Sooners have been led by Jalon Moore, who is averaging 18.8 points per game, and freshman Jeremiah Fears, who is averaging 15.5. Providence has been led by senior guard Bensley Joseph, who is averaging 11.8 points and 4.0 assists per game. Oklahoma has not played a game closer than 16 points yet this season, with an average margin of victory of 24 points. Providence has won its five games by an average of nearly 17 points per game. The teams will square off against either Davidson or No. 24 Arizona in the second round Thursday, with the winners playing each other in one semifinal while the losers play in a consolation semifinal. --Field Level Media
Online auction of confiscated booze features hard-to-find bottles of Kentucky bourbons